The goal of Mayo Clinic's multispecialty team of pediatric experts is to find the most appropriate treatment for patients with achalasia. Careful diagnosis and management can help children lead fulfilling and productive lives.
Dysphagia (difficulty swallowing) is the most common indicator of achalasia in children. Other symptoms include difficulty belching, weight loss, and regurgitation. Chest pain, heartburn, hiccups, and alacrima (triple A syndrome) are sometimes present in children.
The diagnosis of achalasia is generally the same for children and adults.
Specialists in Pediatric Gastroenterology and Hepatology carefully evaluate each child and gather a thorough medical history. Tests, including radiographic studies, manometry tests, and endoscopic evaluation, help physicians confirm the diagnosis and coordinate appropriate treatment.
Achalasia treatment options are generally the same for children and adults.
Medications, such as nitrates, are considered the most noninvasive treatment; however, patients are more likely to experience frequent side effects and a diminished response over time.
More invasive options include botulinum toxin (Botox) injections, used to weaken the sphincter muscle and allow food to pass. This treatment is effective but must be repeated frequently. Other options include pneumatic dilation of the sphincter and surgical myotomy.
For appointments or more information, call the Central Appointment Office at (507) 538-3270 7 a.m. to 7 p.m. Central time Monday through Thursday, 7 a.m. to 5 p.m. Friday.